Safety and Efficacy of BI 695500 in Patients With Moderately to Severely Active Rheumatoid Arthritis

NCT01955733 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

91

Enrollment

INDUSTRY

Sponsor class

Stopped Substance discontinued

Conditions

Arthritis, Rheumatoid

Interventions

DRUG: BI 695500

Sponsor

Boehringer Ingelheim